The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Update on Epstein-Barr virus and gastric cancer (Review)
Open accessAbstract
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is a distinct subtype that accounts for nearly 10% of gastric carcinomas. EBVaGC is defined by monoclonal proliferation of carcinoma cells with latent EBV infection, as demonstrated by EBV-encoded small RNA (EBER) in situ hybridization. EBVaGC has characteristic clinicopathological features, including predominance among males, a proximal location in the stomach, lymphoepithelioma-like histology and a favorable prognosis. EBVaGC belongs to latency type I or II, in which EBERs, EBNA-1, BARTs, LMP-2A and BART miRNAs are expressed. Previous studies have shown that some EBV latent genes have oncogenic properties. Recent advances in genome-wide and comprehensive molecular analyses have demonstrated that both genetic and epigenetic changes contribute to EBVaGC carcinogenesis. Genetic changes that are characteristic of EBVaGC include frequent mutations in PIK3CA and ARID1A and amplification of JAK2 and PD-L1/L2. Global CpG island hypermethylation, which induces epigenetic silencing of tumor suppressor genes, is also a unique feature of EBVaGC and is considered to be crucial for its carcinogenesis. Furthermore, post-transcriptional gene expression regulation by cellular and/or EBV-derived microRNAs has attracted considerable attention. These abnormalities result in significant alterations in gene expression related to cell proliferation, apoptosis, migration and immune signaling pathways. In the present review we highlight the latest findings on EBVaGC from clinicopathological and molecular perspectives to provide a better understanding of EBV involvement in gastric carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Helicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
Identification of Virus-Encoded MicroRNAs
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., et al. (2004) · Science · doi:10.1126/science.1096781 · Cited by 1,621
Chen, B. J., Chapuy, B., Ouyang, J., Sun, H. H., Roemer, M. G. M., Xu, M. L., Yu, H., Fletcher, C. D. M., Freeman, G. J., Shipp, M. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0855 · Cited by 843
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
Green, M. R., Rodig, S., Juszczynski, P., Ouyang, J., Sinha, P., O'Donnell, E., Neuberg, D., & Shipp, M. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1942 · Cited by 685
Epstein-Barr virus-associated gastric adenocarcinoma
Danilova, N. V., Malkov, P. G., Oleynikova, N. A., & Mikhailov, I. A. (2019) · Arkhiv patologii · doi:10.17116/patol20198103174 · Cited by 516
Murphy, G., Pfeiffer, R., Camargo, M. C., & Rabkin, C. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.001 · Cited by 500
An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival
Choy, E. Y.-W., Siu, K.-L., Kok, K.-H., Lung, R. W.-M., Tsang, C. M., To, K.-F., Kwong, D. L.-W., Tsao, S. W., & Jin, D.-Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072581 · Cited by 462
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200312 · Cited by 411
Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1
Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J., Lee, W., Edwards, A. M., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.029 · Cited by 360
Modulation of LMP1 protein expression by EBV-encoded microRNAs
Lo, A. K. F., To, K. F., Lo, K. W., Lung, R. W. M., Hui, J. W. Y., Liao, G., & Hayward, S. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702896104 · Cited by 356
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Skalsky, R. L., Corcoran, D. L., Gottwein, E., Frank, C. L., Kang, D., Hafner, M., Nusbaum, J. D., Feederle, R., Delecluse, H.-J., Luftig, M. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002484 · Cited by 352
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5
Barth, S., Pfuhl, T., Mamiani, A., Ehses, C., Roemer, K., Kremmer, E., Jaker, C., Hock, J., Meister, G., & Grasser, F. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1080 · Cited by 351
Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3070 · Cited by 344
Self-citationEpstein-Barr Virus in Gastric Carcinoma
Nishikawa, J., Yoshiyama, H., Iizasa, H., Kanehiro, Y., Nakamura, M., Nishimura, J., Saito, M., Okamoto, T., Sakai, K., Suehiro, Y., et al. (2014) · Cancers · doi:10.3390/cancers6042259 · Cited by 332
Imai, S., Nishikawa, J., & Takada, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4371-4378.1998 · Cited by 324
EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
Xia, T., O’Hara, A. J., Araújo, I., Barreto, J., Carvalho, E. G., Sapucaia, J. B., Ramos, J. C., Luz, E., Pedroso, C., Manrique, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5126 · Cited by 319
Shibata, D. K., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S., & Weiss, L. M. (1991) · PubMed · Cited by 317
EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latency
Riley, K. J., Rabinowitz, G. S., Yario, T. A., Luna, J. M., Darnell, R. B., & Steitz, J. A. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.63 · Cited by 282
Lee, J., Kim, S., Han, S., An, J., Lee, E., & Kim, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05775.x · Cited by 256
Matsusaka, K., Kaneda, A., Nagae, G., Ushiku, T., Kikuchi, Y., Hino, R., Uozaki, H., Seto, Y., Takada, K., Aburatani, H., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1349 · Cited by 254
Self-citationGruhne, B., Sompallae, R., Marescotti, D., Kamranvar, S. A., Gastaldello, S., & Masucci, M. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810619106 · Cited by 252
Iizasa, H., Wulff, B.-E., Alla, N. R., Maragkakis, M., Megraw, M., Hatzigeorgiou, A., Iwakiri, D., Takada, K., Wiedmer, A., Showe, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138362 · Cited by 250
Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas
Zhu, J. Y., Pfuhl, T., Motsch, N., Barth, S., Nicholls, J., Grässer, F., & Meister, G. (2009) · Journal of Virology · doi:10.1128/jvi.01689-08 · Cited by 240
Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
Lung, R. W.-M., Tong, J. H.-M., Sung, Y.-M., Leung, P.-S., Ng, D. C.-H., Chau, S.-L., Chan, A. W.-H., Ng, E. K.-O., Lo, K.-W., & To, K.-F. (2009) · Neoplasia · doi:10.1593/neo.09888 · Cited by 212
Dölken, L., Malterer, G., Erhard, F., Kothe, S., Friedel, C. C., Suffert, G., Marcinowski, L., Motsch, N., Barth, S., Beitzinger, M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.008 · Cited by 208
Epstein–Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
Kaneda, A., Matsusaka, K., Aburatani, H., & Fukayama, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3919 · Cited by 204
Self-citationSugiura, M., Imai, S., Tokunaga, M., Koizumi, S., Uchizawa, M., Okamoto, K., & Osato, T. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.412 · Cited by 197
The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein Bim
Marquitz, A. R., Mathur, A., Nam, C. S., & Raab-Traub, N. (2011) · Virology · doi:10.1016/j.virol.2011.01.028 · Cited by 194
Song, H., Srivastava, A., Lee, J., Kim, Y. S., Kim, K., Ki Kang, W., Kim, M., Kim, S., Park, C. K., & Kim, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.002 · Cited by 188
Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing
Chen, S.-J., Chen, G.-H., Chen, Y.-H., Liu, C.-Y., Chang, K.-P., Chang, Y.-S., & Chen, H.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012745 · Cited by 185
Co-infections, inflammation and oncogenesis: Future directions for EBV research
Rickinson, A. B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.004 · Cited by 184
Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
Cosmopoulos, K., Pegtel, M., Hawkins, J., Moffett, H., Novina, C., Middeldorp, J., & Thorley-Lawson, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.02104-08 · Cited by 183
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
Camargo, M. C., Murphy, G., Koriyama, C., Pfeiffer, R. M., Kim, W. H., Herrera-Goepfert, R., Corvalan, A. H., Carrascal, E., Abdirad, A., Anwar, M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.215 · Cited by 173
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
Kusano, M., Toyota, M., Suzuki, H., Akino, K., Aoki, F., Fujita, M., Hosokawa, M., Shinomura, Y., Imai, K., & Tokino, T. (2006) · Cancer · doi:10.1002/cncr.21789 · Cited by 167
Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma
Kim, D. N., Chae, H.-S., Oh, S. T., Kang, J.-H., Park, C. H., Park, W. S., Takada, K., Lee, J. M., Lee, W.-K., & Lee, S. K. (2007) · Journal of Virology · doi:10.1128/jvi.02271-06 · Cited by 167
Zhao, J., Liang, Q., Cheung, K., Kang, W., Lung, R. W. M., TONG, J. H. M., To, K. F., Sung, J. J. �., & Yu, J. Q. (2012) · Cancer · doi:10.1002/cncr.27724 · Cited by 161
Strong, M. J., Xu, G., Coco, J., Baribault, C., Vinay, D. S., Lacey, M. R., Strong, A. L., Lehman, T. A., Seddon, M. B., Lin, Z. N., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003341 · Cited by 160
Wong, A. M., Kong, K. L., Tsang, J. W. H., Kwong, D. L. �., & Guan, X. (2011) · Cancer · doi:10.1002/cncr.26309 · Cited by 160
Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma
Shinozaki‐Ushiku, A., Sakatani, T., Ushiku, T., Hino, R., Isogai, M., Ishikawa, S., Uozaki, H., Takada, K., & Fukayama, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4620 · Cited by 160
Self-citationImmune modulation for cancer therapy
Naidoo, J., Page, D. B., & Wolchok, J. D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.348 · Cited by 158
Kim, S. Y., Park, C., Kim, H., Park, J., Hwang, J., Kim, J., Choi, M. G., Kim, S. H., Kim, K., & Kang, M.-S. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.09.020 · Cited by 157
PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy
Dolan, D. E., & Gupta, S. (2014) · Cancer Control · doi:10.1177/107327481402100308 · Cited by 156
Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas
Luo, B. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i5.629 · Cited by 153
A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
Qiu, J. J., Cosmopoulos, K., Pegtel, D. M., Hopmans, E. S., Murray, P. G., Middeldorp, J. M., Shapiro, M., & Thorley‐Lawson, D. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002193 · Cited by 141
Liang, Q., Yao, X., Tang, S., Zhang, J., Yau, T. O., Li, X., Tang, C., Kang, W., Lung, R. W. M., Li, J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.036 · Cited by 140
Gourzonès, C., Gelin, A., Bombik, I., Klibi, J., Vérillaud, B., Guigay, J., Lang, P., Temam, S., Schneider, V., Amiel, C., et al. (2010) · Virology Journal · doi:10.1186/1743-422x-7-271 · Cited by 138
Shannon-Lowe, C. D., Adland, E., Bell, A. I., Delecluse, H., Rickinson, A. B., & Rowe, M. (2009) · Journal of Virology · doi:10.1128/jvi.00108-09 · Cited by 129
MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
Jung, Y., Choi, H., Kim, H., & Lee, S. K. (2014) · Journal of Virology · doi:10.1128/jvi.00721-14 · Cited by 124
Barth, S., Meister, G., & Grässer, F. A. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.010 · Cited by 119
DNA methylation in gastric cancer, related toHelicobacter pyloriand Epstein-Barr virus
Matsusaka, K., Funata, S., Fukayama, M., & Kaneda, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3916 · Cited by 114
Self-citationHsu, C., Yi, Y.-H., Chang, K., Chang, Y., Chen, S., & Chen, H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003974 · Cited by 113
Role of EBERs in the Pathogenesis of EBV Infection
Iwakiri, D., & Takada, K. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07004-1 · Cited by 112
Lu, J. L., Murakami, M., Verma, S. C., Cai, Q., Haldar, S., Kaul, R., Wasik, M. A., Middeldorp, J. M., & Robertson, E. S. (2010) · Virology · doi:10.1016/j.virol.2010.10.029 · Cited by 111
Abé, H., Maeda, D., Hino, R., Otake, Y., Isogai, M., Ushiku, A. S., Matsusaka, K., Kunita, A., Ushiku, T., Uozaki, H., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1303-2 · Cited by 105
Self-citationContributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Sivachandran, N., Dawson, W. O., Young, L. S., Liu, F., Middeldorp, J. M., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05623-11 · Cited by 103
van Beek, J., Hausen, A. Z., Snel, S. N., Berkhof, J. H., Kranenbarg, E. M., van de Velde, C. J. �., van den Brule, A. J. C., Middeldorp, J. M., Meijer, C. J. L. M., & Bloemena, E. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176428.06629.1e · Cited by 100
Yin, Q., & Flemington, E. K. (2005) · Virology · doi:10.1016/j.virol.2005.11.021 · Cited by 99
Hino, R., Uozaki, H., Inoue, Y., Shintani‐Domoto, Y., Ushiku, T., Sakatani, T., Takada, K., & Fukayama, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3027 · Cited by 95
Self-citationMicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing
Motsch, N., Alles, J., Imig, J., Zhu, J., Barth, S., Reineke, T., Tinguely, M., Cogliatti, S., Dueck, A., Meister, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042193 · Cited by 94
Pal, A. D., Basak, N. P., Banerjee, A. S., & Banerjee, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu069 · Cited by 93
Marquitz, A. R., Mathur, A., Shair, K. H. Y., & Raab‐Traub, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202910109 · Cited by 88
Ambrosio, M. R., Navari, M., Lisio, L. D., Andrés‐León, E., Onnis, A., Gazaneo, S., Mundo, L., Ulivieri, C., Goméz-López, G., Lazzi, S., et al. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-12 · Cited by 88
Sukawa, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6577 · Cited by 86
Lee, J., Hummelen, P. V., Go, C. K., Palescandolo, E., Jang, J., Park, H. Y., Kang, S. Y., Park, J. O., Kang, W. K., MacConaill, L. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038892 · Cited by 78
Hong, M., Murai, Y., Kutsuna, T., Takahashi, H., Nomoto, K., Cheng, C., Ishizawa, S., Zhao, Q., Ogawa, R., HARMON, B. V., et al. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0036-x · Cited by 74
Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments
Yau, T. O., Tang, C.-M., & Yu, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i21.6448 · Cited by 74
Qiu, J. J., & Thorley‐Lawson, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406136111 · Cited by 73
Chang, M. S., Kim, D. H., Roh, J., Middeldorp, J. M., Kim, Y. S., Kim, S., Han, S., Kim, C. W., Lee, B. L., Kim, W. H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00955-13 · Cited by 70
Ramakrishnan, R., Donahue, H., Garcia, D., Tan, J., Shimizu, N., Rice, A., & Ling, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027271 · Cited by 69
Characterization of naturally Epstein–Barr virus-infected gastric carcinoma cell line YCCEL1
Kim, D. N., Seo, M. K., Choi, H., Kim, S. Y., Shin, H. J., Yoon, A.-R., Tao, Q., Rha, S. Y., & Lee, S. K. (2012) · Journal of General Virology · doi:10.1099/vir.0.045237-0 · Cited by 69
BamHI‐A rightward frame 1, an Epstein–Barr virus‐encoded oncogene and immune modulator
Hoebe, E. K., Large, T. Y. S. L., Greijer, A. E., & Middeldorp, J. M. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1758 · Cited by 53
Epstein–Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
Banerjee, A. S., Pal, A. D., & Banerjee, S. (2013) · Virology · doi:10.1016/j.virol.2013.05.020 · Cited by 52
Gourzonès, C., Ferrand, F., Amiel, C., Vérillaud, B., Barat, A., Guérin, M., Gattolliat, C., Gelin, A., Klibi, J., Chaaben, A. B., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-119 · Cited by 52
Zong, L., & Seto, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086097 · Cited by 49
Role of DNA methylation in the development of Epstein–Barr virus‐associated gastric carcinoma
Saito, M. K., Nishikawa, J., Okada, T., Morishige, A., Sakai, K., Nakamura, M., Kiyotoki, S., Hamabe, K., Okamoto, T., Oga, A., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23405 · Cited by 34
Sheu (2009) · International Journal of Oncology · doi:10.3892/ijo_00000486 · Cited by 33
The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.
Ross, N., Gandhi, M. K., & Nourse, J. P. (2013) · Europe PMC (PubMed Central) · Cited by 30
Biogenesis of Epstein–Barr virus microRNAs
Kim, D. N., & Lee, S. K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1261-7 · Cited by 29
Park, H. Y., Kang, S. Y., Kang, G. H., et al. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23131 · Cited by 9
Cited by
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
Moon, J. W., Kong, S.-K., Kim, B. S., Kim, H. J., Lim, H., Noh, K., Kim, Y., Choi, J.-W., Lee, J.-H., & Kim, Y.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-18132-0 · Cited by 162
Metadata
- Authors
- SHINOZAKI-USHIKU, A., KUNITA, A., & FUKAYAMA, M.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2015-01-28
- Volume
- 46
- Issue
- 4
- Pages
- 1421-1434
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2008062656
- Cited by
- 286
- References
- 87
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.